Management of patients with hepatitis C virus genotype 2 or 3: Comments on updated american association for the study of liver diseases practice guidelines

Authors


  • Potential conflict of interest: Dr. Dalgard is a consultant for Schering-Plough.

No abstract is available for this article.

Ancillary